541 related articles for article (PubMed ID: 30397057)
21. Lipid core nanoparticles as a broad strategy to reverse fluconazole resistance in multiple Candida species.
Domingues Bianchin M; Borowicz SM; da Rosa Monte Machado G; Pippi B; Stanisçuaski Guterres S; Raffin Pohlmann A; Meneghello Fuentefria A; Clemes Külkamp-Guerreiro I
Colloids Surf B Biointerfaces; 2019 Mar; 175():523-529. PubMed ID: 30579053
[TBL] [Abstract][Full Text] [Related]
22. The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance.
Alvarez-Rueda N; Fleury A; Logé C; Pagniez F; Robert E; Morio F; Le Pape P
Med Mycol; 2016 Oct; 54(7):764-775. PubMed ID: 27143634
[TBL] [Abstract][Full Text] [Related]
23. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
Sanglard D; Ischer F; Koymans L; Bille J
Antimicrob Agents Chemother; 1998 Feb; 42(2):241-53. PubMed ID: 9527767
[TBL] [Abstract][Full Text] [Related]
24. The Evolution of Azole Resistance in
Warrilow AG; Nishimoto AT; Parker JE; Price CL; Flowers SA; Kelly DE; Rogers PD; Kelly SL
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30783005
[TBL] [Abstract][Full Text] [Related]
25. Use of a yeast-based membrane protein expression technology to overexpress drug resistance efflux pumps.
Lamping E; Cannon RD
Methods Mol Biol; 2010; 666():219-50. PubMed ID: 20717788
[TBL] [Abstract][Full Text] [Related]
26. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
Coste AT; Ramsdale M; Ischer F; Sanglard D
Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058
[TBL] [Abstract][Full Text] [Related]
27. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.
Shekhar-Guturja T; Tebung WA; Mount H; Liu N; Köhler JR; Whiteway M; Cowen LE
Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764
[TBL] [Abstract][Full Text] [Related]
28. VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
Break TJ; Desai JV; Natarajan M; Ferre EMN; Henderson C; Zelazny AM; Siebenlist U; Hoekstra WJ; Schotzinger RJ; Garvey EP; Lionakis MS
J Antimicrob Chemother; 2018 Jan; 73(1):151-155. PubMed ID: 29040636
[TBL] [Abstract][Full Text] [Related]
29. An Erg11 lanosterol 14-α-demethylase-Arv1 complex is required for Candida albicans virulence.
Villasmil ML; Barbosa AD; Cunningham JL; Siniossoglou S; Nickels JT
PLoS One; 2020; 15(7):e0235746. PubMed ID: 32678853
[TBL] [Abstract][Full Text] [Related]
30. Vanillin confers antifungal drug synergism in Candida albicans by impeding CaCdr2p driven efflux.
Saibabu V; Fatima Z; Singh S; Khan LA; Hameed S
J Mycol Med; 2020 Apr; 30(1):100921. PubMed ID: 31937429
[TBL] [Abstract][Full Text] [Related]
31. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
Sanglard D; Ischer F; Monod M; Bille J
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51.
Zhao S; Wei P; Wu M; Zhang X; Zhao L; Jiang X; Hao C; Su X; Zhao D; Cheng M
Bioorg Med Chem; 2018 Jul; 26(12):3242-3253. PubMed ID: 29748145
[TBL] [Abstract][Full Text] [Related]
33. Modulation of the antifungal activity of new medicinal plant extracts active on Candida glabrata by the major transporters and regulators of the pleiotropic drug-resistance network in Saccharomyces cerevisiae.
Kolaczkowski M; Kolaczkowska A; Stermitz FR
Microb Drug Resist; 2009 Mar; 15(1):11-7. PubMed ID: 19216644
[TBL] [Abstract][Full Text] [Related]
34. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
Schuetzer-Muehlbauer M; Willinger B; Egner R; Ecker G; Kuchler K
Int J Antimicrob Agents; 2003 Sep; 22(3):291-300. PubMed ID: 13678837
[TBL] [Abstract][Full Text] [Related]
35. Magnitude of Voriconazole Resistance in Clinical and Environmental Isolates of Aspergillus flavus and Investigation into the Role of Multidrug Efflux Pumps.
Paul RA; Rudramurthy SM; Dhaliwal M; Singh P; Ghosh AK; Kaur H; Varma S; Agarwal R; Chakrabarti A
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126956
[TBL] [Abstract][Full Text] [Related]
36. Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function.
Tanabe K; Lamping E; Nagi M; Okawada A; Holmes AR; Miyazaki Y; Cannon RD; Monk BC; Niimi M
Mol Microbiol; 2011 Oct; 82(2):416-33. PubMed ID: 21895791
[TBL] [Abstract][Full Text] [Related]
37. Atomic modelling and systematic mutagenesis identify residues in multiple drug binding sites that are essential for drug resistance in the major Candida transporter Cdr1.
Nim S; Lobato LG; Moreno A; Chaptal V; Rawal MK; Falson P; Prasad R
Biochim Biophys Acta; 2016 Nov; 1858(11):2858-2870. PubMed ID: 27569110
[TBL] [Abstract][Full Text] [Related]
38. Enhanced susceptibility to antifungal oligopeptides in yeast strains overexpressing ABC multidrug efflux pumps.
Wakiec R; Gabriel I; Prasad R; Becker JM; Payne JW; Milewski S
Antimicrob Agents Chemother; 2008 Nov; 52(11):4057-63. PubMed ID: 18794383
[TBL] [Abstract][Full Text] [Related]
39. Substrates and modulators of the multidrug transporter Cdr1p of Candida albicans in antifungal extracts of medicinal plants.
Kolaczkowski M; Kolaczkowska A; Sroda K; Ramalhete C; Michalak K; Mulhovo S; Ferreira MJ
Mycoses; 2010 Jul; 53(4):305-10. PubMed ID: 19460101
[TBL] [Abstract][Full Text] [Related]
40. Enhanced Efflux Pump Activity in Old Candida glabrata Cells.
Bhattacharya S; Fries BC
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
